GMP production of .sup.68Ga-labelled DOTA-NOC on IBA Synthera

.sup.68Ga labelled peptides are increasingly being used clinically due to widespread availability of .sup.68Ge/.sup.68Ga generators and their recognised importance in the diagnosis of neuroendocrine tumours. A simple and reproducible GMP-compliant process for labelling peptides with generator-produc...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of radioanalytical and nuclear chemistry 2015-08, Vol.305 (2), p.501
Hauptverfasser: Alves, Vitor H, Prata, M. I. M, Abrunhosa, Antero J, Castelo-Branco, Miguel
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 2
container_start_page 501
container_title Journal of radioanalytical and nuclear chemistry
container_volume 305
creator Alves, Vitor H
Prata, M. I. M
Abrunhosa, Antero J
Castelo-Branco, Miguel
description .sup.68Ga labelled peptides are increasingly being used clinically due to widespread availability of .sup.68Ge/.sup.68Ga generators and their recognised importance in the diagnosis of neuroendocrine tumours. A simple and reproducible GMP-compliant process for labelling peptides with generator-produced .sup.68Ga is crucial to meet current pharmaceutical requirements. Here, we describe the development of a cassette-based .sup.68Ga-radiolabelling process using an automated commercial synthesizer coupled with a standard .sup.68Ge/.sup.68Ga generator. The radiolabeled somatostatin analogue [.sup.68Ga]DOTA-NOC was successfully synthesized in about 30 min with 80.3 ± 3.20 % of decay corrected radiochemical yield. The process is easily adaptable to the labelling of other peptides such as DOTA-TOC or DOTA-TATE for diagnosis or therapy.
doi_str_mv 10.1007/s10967-015-3989-5
format Article
fullrecord <record><control><sourceid>gale</sourceid><recordid>TN_cdi_gale_infotracacademiconefile_A421961206</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A421961206</galeid><sourcerecordid>A421961206</sourcerecordid><originalsourceid>FETCH-gale_infotracacademiconefile_A4219612063</originalsourceid><addsrcrecordid>eNqVi7sOgjAYRjtoIl4ewK0vUPxLpdDBAfE6KCaymwpFMZUSCoNvL4MvYL7hJCfnQ2hOwaUAwcJSEDwgQH3CRCiIP0AOeIwTP2B0hMbWvgBAhCFz0Gp_uuC6MXmXtaWpsCmwa7va5eFeEi3vSmuV402SRuScxLgvjusIXz9V-1SNnKJhIbVVsx8nyN1t0_hAHlKrW1kVpm1k1i9X7zIzlSrK3kdLjwpOPeDs78MXbodCNQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>GMP production of .sup.68Ga-labelled DOTA-NOC on IBA Synthera</title><source>SpringerLink (Online service)</source><creator>Alves, Vitor H ; Prata, M. I. M ; Abrunhosa, Antero J ; Castelo-Branco, Miguel</creator><creatorcontrib>Alves, Vitor H ; Prata, M. I. M ; Abrunhosa, Antero J ; Castelo-Branco, Miguel</creatorcontrib><description>.sup.68Ga labelled peptides are increasingly being used clinically due to widespread availability of .sup.68Ge/.sup.68Ga generators and their recognised importance in the diagnosis of neuroendocrine tumours. A simple and reproducible GMP-compliant process for labelling peptides with generator-produced .sup.68Ga is crucial to meet current pharmaceutical requirements. Here, we describe the development of a cassette-based .sup.68Ga-radiolabelling process using an automated commercial synthesizer coupled with a standard .sup.68Ge/.sup.68Ga generator. The radiolabeled somatostatin analogue [.sup.68Ga]DOTA-NOC was successfully synthesized in about 30 min with 80.3 ± 3.20 % of decay corrected radiochemical yield. The process is easily adaptable to the labelling of other peptides such as DOTA-TOC or DOTA-TATE for diagnosis or therapy.</description><identifier>ISSN: 0236-5731</identifier><identifier>DOI: 10.1007/s10967-015-3989-5</identifier><language>eng</language><publisher>Springer</publisher><subject>Peptides</subject><ispartof>Journal of radioanalytical and nuclear chemistry, 2015-08, Vol.305 (2), p.501</ispartof><rights>COPYRIGHT 2015 Springer</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>Alves, Vitor H</creatorcontrib><creatorcontrib>Prata, M. I. M</creatorcontrib><creatorcontrib>Abrunhosa, Antero J</creatorcontrib><creatorcontrib>Castelo-Branco, Miguel</creatorcontrib><title>GMP production of .sup.68Ga-labelled DOTA-NOC on IBA Synthera</title><title>Journal of radioanalytical and nuclear chemistry</title><description>.sup.68Ga labelled peptides are increasingly being used clinically due to widespread availability of .sup.68Ge/.sup.68Ga generators and their recognised importance in the diagnosis of neuroendocrine tumours. A simple and reproducible GMP-compliant process for labelling peptides with generator-produced .sup.68Ga is crucial to meet current pharmaceutical requirements. Here, we describe the development of a cassette-based .sup.68Ga-radiolabelling process using an automated commercial synthesizer coupled with a standard .sup.68Ge/.sup.68Ga generator. The radiolabeled somatostatin analogue [.sup.68Ga]DOTA-NOC was successfully synthesized in about 30 min with 80.3 ± 3.20 % of decay corrected radiochemical yield. The process is easily adaptable to the labelling of other peptides such as DOTA-TOC or DOTA-TATE for diagnosis or therapy.</description><subject>Peptides</subject><issn>0236-5731</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid/><recordid>eNqVi7sOgjAYRjtoIl4ewK0vUPxLpdDBAfE6KCaymwpFMZUSCoNvL4MvYL7hJCfnQ2hOwaUAwcJSEDwgQH3CRCiIP0AOeIwTP2B0hMbWvgBAhCFz0Gp_uuC6MXmXtaWpsCmwa7va5eFeEi3vSmuV402SRuScxLgvjusIXz9V-1SNnKJhIbVVsx8nyN1t0_hAHlKrW1kVpm1k1i9X7zIzlSrK3kdLjwpOPeDs78MXbodCNQ</recordid><startdate>20150801</startdate><enddate>20150801</enddate><creator>Alves, Vitor H</creator><creator>Prata, M. I. M</creator><creator>Abrunhosa, Antero J</creator><creator>Castelo-Branco, Miguel</creator><general>Springer</general><scope/></search><sort><creationdate>20150801</creationdate><title>GMP production of .sup.68Ga-labelled DOTA-NOC on IBA Synthera</title><author>Alves, Vitor H ; Prata, M. I. M ; Abrunhosa, Antero J ; Castelo-Branco, Miguel</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-gale_infotracacademiconefile_A4219612063</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Peptides</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Alves, Vitor H</creatorcontrib><creatorcontrib>Prata, M. I. M</creatorcontrib><creatorcontrib>Abrunhosa, Antero J</creatorcontrib><creatorcontrib>Castelo-Branco, Miguel</creatorcontrib><jtitle>Journal of radioanalytical and nuclear chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Alves, Vitor H</au><au>Prata, M. I. M</au><au>Abrunhosa, Antero J</au><au>Castelo-Branco, Miguel</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>GMP production of .sup.68Ga-labelled DOTA-NOC on IBA Synthera</atitle><jtitle>Journal of radioanalytical and nuclear chemistry</jtitle><date>2015-08-01</date><risdate>2015</risdate><volume>305</volume><issue>2</issue><spage>501</spage><pages>501-</pages><issn>0236-5731</issn><abstract>.sup.68Ga labelled peptides are increasingly being used clinically due to widespread availability of .sup.68Ge/.sup.68Ga generators and their recognised importance in the diagnosis of neuroendocrine tumours. A simple and reproducible GMP-compliant process for labelling peptides with generator-produced .sup.68Ga is crucial to meet current pharmaceutical requirements. Here, we describe the development of a cassette-based .sup.68Ga-radiolabelling process using an automated commercial synthesizer coupled with a standard .sup.68Ge/.sup.68Ga generator. The radiolabeled somatostatin analogue [.sup.68Ga]DOTA-NOC was successfully synthesized in about 30 min with 80.3 ± 3.20 % of decay corrected radiochemical yield. The process is easily adaptable to the labelling of other peptides such as DOTA-TOC or DOTA-TATE for diagnosis or therapy.</abstract><pub>Springer</pub><doi>10.1007/s10967-015-3989-5</doi></addata></record>
fulltext fulltext
identifier ISSN: 0236-5731
ispartof Journal of radioanalytical and nuclear chemistry, 2015-08, Vol.305 (2), p.501
issn 0236-5731
language eng
recordid cdi_gale_infotracacademiconefile_A421961206
source SpringerLink (Online service)
subjects Peptides
title GMP production of .sup.68Ga-labelled DOTA-NOC on IBA Synthera
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-14T18%3A55%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=GMP%20production%20of%20.sup.68Ga-labelled%20DOTA-NOC%20on%20IBA%20Synthera&rft.jtitle=Journal%20of%20radioanalytical%20and%20nuclear%20chemistry&rft.au=Alves,%20Vitor%20H&rft.date=2015-08-01&rft.volume=305&rft.issue=2&rft.spage=501&rft.pages=501-&rft.issn=0236-5731&rft_id=info:doi/10.1007/s10967-015-3989-5&rft_dat=%3Cgale%3EA421961206%3C/gale%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_galeid=A421961206&rfr_iscdi=true